Literature DB >> 32056744

The role of serum oxytocin levels in the second trimester in regulating prenatal anxiety and depression: A sample from Shanghai Maternal-Child Pairs Cohort study.

Xuemei Ma1, Qian Wei1, Zihan Jiang1, Yuyang Shi1, Yunhui Zhang2, Huijing Shi3.   

Abstract

BACKGROUND: Recent research suggested that oxytocin might be associated with prenatal anxiety or depression. Also, our previous study indicated that resilience could buffer the effect of stress on prenatal anxiety and depression, which is a kind of psychological adjustment ability to stress in life. The effects of oxytocin and resilience are supposed to be similar but no study was carried out to find the association between them. Current evidence on the effect of oxytocin on prenatal mental health were with small sample size and equivocal results, especially with a lack of studies in Chinese pregnant women. AIMS: To investigate the relationship between oxytocin and resilience, and its role in regulating prenatal anxiety and depression among Chinese women.
METHODS: The study was based on a sub-sample of the Shanghai Maternal-Child Pairs Cohort (Shanghai MCPC) by stratified random sampling. A total of 632 participants completed blood collection for serum oxytocin measurement and questionnaires pertaining to early pregnancy stress and resilience in the second trimester, which were assessed by the Life Event Scale for Pregnancy Women (LESPW) and the revised Resilience Scale for Adults (RSA), respectively. Prenatal anxiety and depression were assessed by Self-Rating Anxiety Scale (SAS) and the Center for Epidemiological Survey, Depression Scale (CES-D), respectively, at the third trimester. Correlation analysis and stratified linear regression analyses were conducted to understand the role of oxytocin in regulating prenatal anxiety and depression.
RESULTS: The concentration of serum oxytocin in the second trimester ranged from 98.14 pg⋅ml-1 to 197.28 pg⋅ml-1, and there was no significant difference between different gestational age (r = 0.024, P = 0.579). The association between stress and prenatal anxiety was stronger in high oxytocin group than that in low oxytocin group, with B value of 3.338 and 2.638, respectively, after adjusting for residence, educational level, family income and parity. The same effect was found in the association between stress and prenatal depression, with B value of 2.360 and 2.060, respectively. However, it was not significantly associated with early pregnancy stress (Z = 1.933, P = 0.630), prenatal anxiety (Z = 1.387, P = 0.165), prenatal depression (Z = -0.027, P = 0.978), nor resilience (F = 1.282, P = 0.280). LIMITATIONS: The existence of recall bias and restricted residential areas of the participants may limit the extrapolation of the study. Also, unsynchronized sampling timing of the oxytocin and psychological resilience measures is another limitation.
CONCLUSIONS: Serum oxytocin levels in the second trimester had an effect of modification between early pregnancy stress and prenatal anxiety and depression. Pregnant women with high oxytocin in the second trimester should receive more attention and further study is needed on the mechanism of oxytocin for the mental health of pregnant women.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anxiety; Depression; Oxytocin; Pregnancy; Resilience

Mesh:

Substances:

Year:  2019        PMID: 32056744     DOI: 10.1016/j.jad.2019.12.019

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  2 in total

1.  The Role of OXT, OXTR, AVP, and AVPR1a Gene Expression in the Course of Schizophrenia.

Authors:  Marta Broniarczyk-Czarniak; Janusz Szemraj; Janusz Śmigielski; Piotr Gałecki
Journal:  Curr Issues Mol Biol       Date:  2022-01-12       Impact factor: 2.976

2.  The Effect of Humanistic Care Combined with Predictive Nursing on Negative Emotions and Incidence of Cardiovascular Events in Hemodialysis Patients.

Authors:  Yanling Wang; Changmin Su
Journal:  Comput Math Methods Med       Date:  2022-04-29       Impact factor: 2.238

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.